---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-078375"
form_type: "8-K"
ticker: "OKUR"
cik: "0001637715"
company_name: "OnKure Therapeutics, Inc."
filed_at: "2025-05-28T23:59:59+00:00"
generated_at: "2026-05-20T08:11:13.977161+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# OnKure shareholders elect Manke and Saccomano as Class I directors, ratify KPMG as auditor for FY2025

## Summary
- Dr. Isaac Manke elected with 4,589,481 for, 882,303 withheld; Dr. Nicholas Saccomano with 5,209,380 for, 262,404 withheld.
- KPMG LLP ratified as independent auditor for fiscal year ending December 31, 2025 (6,750,408 for, 111,715 against, 208 abstain).
- Both directors will serve until the 2028 annual meeting of stockholders.
- Broker non-votes totaled 1,390,547 for each director proposal.

## SEC filing metadata
- accession: 0000950170-25-078375
- form_type: 8-K
- ticker: OKUR
- cik: 0001637715
- company_name: OnKure Therapeutics, Inc.
- filed_at: 2025-05-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1637715/000095017025078375/0000950170-25-078375-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1637715/000095017025078375/okur-20250527.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-078375
- JSON: https://secwatch.observer/filing/0000950170-25-078375.json
- Plain text: https://secwatch.observer/filing/0000950170-25-078375.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.